BioPharm Solutions, Inc. (BPS) is a specialty pharmaceutical company that develops solutions for sustained release drug delivery systems for difficult-to-formulate drugs, especially delicate biopharmaceuticals, using its patented proprietary technologies, which include sustained-release injection and transdermal administration of proteins and peptides. The company's vision is to ultimately unlock the therapeutic potentials and benefits for a wide range of existing and new biopharmaceutical preparations via developing and advancing innovative and breakthrough sustained release formulations of proteins, monoclonal antibodies, peptides, DNA, lipsomes, and live viruses.
